key: cord-0986196-us34twfj authors: Yang, Jianing; Zhang, Guoqing; Yu, Dalang; Cao, Ruifang; Wu, Xiaoxian; Ling, Yunchao; Pan, Yi-Hsuan; Yi, Chunyan; Sun, Xiaoyu; Sun, Bing; Zhang, Yu; Zhao, Guo-Ping; Li, Yixue; Li, Haipeng title: A Kozak-related non-coding deletion effectively increases B.1.1.7 transmissibility date: 2021-07-06 journal: bioRxiv DOI: 10.1101/2021.04.30.442029 sha: a19ba7fde89e4a6a8ecf3d2383b76293f2dc7137 doc_id: 986196 cord_uid: us34twfj The high transmissibility acquisition of SARS-CoV-2 Variant of Concern (VOC) B.1.1.7 remains unclear and only mutations in coding regions have been examined. We analyzed 875,338 high-quality SARS-CoV-2 genomic sequences and the epidemiology metadata. The occurrence of a non-coding deletion (g.a28271-) in the B.1.1.7 background immediately causes the rapid spread of B.1.1.7. The number of B.1.1.7-like strains lacking the deletion is significantly less than that of B.1.1.7 strains (n = 259 vs 92,688, P-value< 4.9 × 10−324). The same highly significant statistics is observed in different countries, gender and age groups. However, the deletion alone does not cause such high viral transmissibility. The deletion and another mutation (g.gat28280cta) co-affect translational efficiency of the genes N and ORF9b by changing the core Kozak sites. The deletion interacts synergistically with S:p.P681H and S:p.T716I to increase viral transmissibility. Therefore, the Kozak-related non-coding deletion, also carried by the Delta VOC, is crucial for the high viral transmissibility of SARS-CoV-2. SARS-CoV-2 lineage B.1.1.7, also known as Variant of Concern (VOC) 46 202012/01 or the Alpha VOC, is a variant first detected in the UK in September 2020 47 (1) and has higher transmissibility than the preexisting variants (2). Its high 48 transmissibility remains similar across different age, sex and socioeconomic strata (3). 49 It has spread to 97 countries/regions within seven months and its global infection Table S1 ) (5). Among them, it was previously found that each 55 of the mutations S:p.N501Y (6, 7) and S:p.D614G (8, 9) may increase the viral 56 transmissibility, and S:p.P681H, located on the spike S1/S2 cleavage site, may affect 57 the cleavableness and activation of the spike protein (1, 10) . However, the crucial interactions. We also found that the non-coding deletion is carried by the Delta VOC. (Table 1 , P-value≤ 2.74 × 10 −6 ). The same highly significant 161 statistics was observed in 10 more countries, such as India and Italy. Moreover, the 162 same conclusion holds when considering different gender and age groups 163 (Supplementary Tables S2, S3) . Therefore, the non-coding deletion g.a28271- In this study, we find that the non-coding deletion g.a28271-plays an essential Preliminary genomic characterisation of 262 an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike 263 mutations s-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 Assessing transmissibility of SARS-CoV-2 267 1.1.7 in England Estimated transmissibility and impact 269 of SARS-CoV-2 lineage B.1.1.7 in England A new coronavirus associated with human 271 respiratory disease in China Deep mutational scanning of 277 SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 278 binding Detection of a SARS-CoV-2 280 variant of concern in South Africa SARS-CoV-2 spike D614G change 282 enhances replication and transmission Spike: Evidence that D614G increases infectivity of the COVID-19 virus Coronavirus biology and replication: 287 implications for SARS-CoV-2 SARS-CoV-2 on spike structure, conformation, and antigenicity Evolution of enhanced innate 291 immune evasion by the SARS-CoV-2 B.1.1.7 UK variant. bioRxiv Functional evaluation of proteolytic 293 activation for the SARS-CoV-2 variant B.1.1.7: role of the P681H mutation Higher infectivity of the SARS-CoV-2 new 296 variants is associated with K417N/T, E484K, and N501Y mutants: An insight 297 from structural data The N501Y spike substitution enhances 299 SARS-CoV-2 transmission Structural basis for enhanced infectivity and 301 immune evasion of SARS-CoV-2 variants Nextstrain: real-time tracking of pathogen 303 evolution Coronavirus GenBrowser for monitoring the 305 transmission and evolution of SARS-CoV-2. medRxiv An interactive viral genome evolution network 307 analysis system enabling rapid large-scale molecular tracing of SARS-CoV-2 An online coronavirus analysis platform from 312 the National Genomics Data Center Data, disease and diplomacy: GISAID's innovative 314 contribution to global health Global initiative on sharing all influenza data -316 from vision to reality Database resources of the National Center 318 13 for Biotechnology Information The effect of large-scale anti-contagion 324 policies on the COVID-19 pandemic Proteomics of SARS-CoV-2-infected host 326 cells reveals therapy targets Selective replication of coronavirus 328 genomes that express nucleocapsid protein At least six nucleotides preceding the AUG initiator codon enhance 330 translation in mammalian cells Severe acute respiratory syndrome coronavirus 332 accessory protein 9b is a virion-associated protein SARS-CoV-2 ORF9b inhibits RIG-I-MAVS 334 antiviral signaling by interrupting K63-linked ubiquitination of NEMO Improved algorithmic complexity for the 337 3SEQ recombination detection algorithm On the origin and continuing evolution of 339 SARS-CoV-2 A) CGB evolutionary tree of SARS-CoV-2 lineage B.1.1.7. The analysis was 344 performed on 400,051 high-quality SARS-CoV-2 genomic sequences using the 345 The searchable CGB ID of the internal node with 346 g.a28271-is CGB84017.91425, assigned by the CGB binary nomenclature system The number of B.1.1.7-like and B.1.1.7 These six countries and three continents were shown in Figure 2A .